Navigation Links
Safe in Common's "The Unfinished Agenda: Addressing the Challenges" Crystalizes Call for Unified Protection Against Needlestick and Sharps Injuries
Date:2/20/2013

inue to face daily harm."

Other practices recommended by a panel of experts from The Association of Perioperative Registered Nurses (AORN) include double gloving, the use of a neutral zone for passing, and the use of safety-engineered devices, yet none of these practices were being deployed by a majority of respondents.

Nearly 62 percent of the attendees said they are using sharps injury data in making purchasing decisions for medical devices. In a sign of progress, some 61 percent said that in 2012 they participated in an engineering control evaluation and/or annual exposure control plan review. Dr. Foley said "although 61% of the participants have been involved, we still have a lot of work to do to improve those numbers and grow awareness to 85% or greater – which is all evidence of the need to support the Unfinished Agenda Online Conference series."

An interactive edition of the online conference is available for replay on http://www.youtube.com/watch?feature=player_embedded&v=_RlH5YLb8p8. The event also featured unprecedented participation from a panel of experts:

  • Mary Ogg , MSN, RN, CNOR and Perioperative Nursing Specialist from The Association of Perioperative Registered Nurses (AORN)
  • Donna A. Ford , MSN, RN-BC, CNOR, Nursing Education Specialist, Division of Surgical Services, Department of Nursing, and an Assistant Professor of Nursing, College of Medicine, Mayo Clinic; AORN National Clinical Nursing Practice Committee
  • Deborah Spratt MPA, BSN, RN, CNOR, NEA-BC, CRCST, CHL, Manager of Sterile Processing at the Canandaigua VAMC in Canandaigua NY; AORN President
  • Angela Laramie , Epidemiologist with the Sharps Injury Surveillance Project in the Occupat
    '/>"/>

SOURCE Safe in Common
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Executive Insight Hosts Webinar "The Hospital Pharmacy as a Revenue Center"
2. Science Translational Medicine and the DMM Global Foundation Announce Days of Molecular Medicine 2012 "The Translational Science of Rare Diseases: From Rare To Care."
3. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
4. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
5. Physician-Patient Alliance for Health & Safety: Addressing The Joint Commission Opioid Warnings Can Reduce Respiratory Depression and Improve Patient Safety in Hospitals
6. ViiV Healthcare Expands Commitment to Addressing Gaps in Paediatric HIV Research, Care and Treatment
7. Frost & Sullivan Recognizes Labcyte for its Commitment to Innovation and Addressing Unmet Needs in the Liquid Handling Market
8. Radiation Detection/Protection Market Worth $1,231 Million - 2017
9. Diet Doc Weight Loss Diets and Fast Weight Loss Plans To Seek Patent Protection for the Most Clinically Advanced Diet Offered in the United States.
10. Ansell y Comasec presentan Shared World of Innovation en ExpoProtection 2012
11. Ansell and Comasec Unveil Shared World of Innovation at ExpoProtection 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... WESTBURY, N.Y. , May 21, 2013  Vasomedical, Inc. ... specializing in the design, manufacture and sale of medical devices ... today that Dr. Jun Ma , President ... Annual Marcum LLP MicroCap Conference on Thursday, May 30, 2013 ... Grand Hyatt Hotel. The Company,s presentation is ...
(Date:5/21/2013)... , May 21, 2013 ... report is available in its catalogue: ... and Technologies for Optical Coherence Tomography (OCT) ... STUDY OBJECTIVES   ... study is to offer synopsis of the ...
(Date:5/21/2013)... Fla. , May 21, 2013  Janssen ... safety results from the global Phase 3 PROMISE ... inhibitor simeprevir (TMC435) led to sustained virologic response ... in 79 percent of treatment-experienced genotype 1 chronic ... including all stages of liver fibrosis, when administered ...
Breaking Medicine Technology:Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will ... Conference on Monday, September 20, 2010.  The presentation is ... be accessed through the Company,s web site, www.regeneron.com ... of the presentation will be available after the live ...
... Shield Healthcare, a leading provider of medical supplies for ... annual story contest on "What Makes Caregiving Rewarding?" designed ... home healthcare  professionals, featuring celebrity contest judge, Sandra Mitchell ... caregiving is a demanding job. A significant number of ...
Cached Medicine Technology:Shield Healthcare Announces 10th Annual Caregiver Story Contest 2
(Date:5/21/2013)... HealthDay Reporter , , TUESDAY, May 21 (HealthDay News) -- ... some of the changes brought about by the disorder ... New research has found that people with diabetes who ... risk of having a severe low blood sugar (hypoglycemia) ... people with diabetes who aren,t depressed. "Depression ...
(Date:5/21/2013)... long been known for their health benefits, and ... like anti-cancer drugs are delivered to specific tumor ... how to create nanoparticles using natural lipids derived ... them as drug delivery vehicles. UofL scientists Huang-Ge ... team today (May 21, 2013), published their findings ...
(Date:5/21/2013)... Schaumburg, IL (PRWEB) May 21, 2013 ... administration for large, medium, and small organizations, will be ... featuring an experts team from Findley Davies. The presentation ... is up-to-date and in compliance with new Health Care ... ideas to engage employees. , “Benefit Express regularly ...
(Date:5/21/2013)... May 21, 2013 Dr. Francine Kaufman , ... she used with her patients in the 1980s: It weighed several ... For the most part, it could only be used in the ... years since then, and the advantages are greater as well. The ... outside of the body, often on a belt or a pocket. ...
(Date:5/21/2013)... 21, 2013 A plastic surgery ... for plastic surgery SEO services following an Internet ... to name the “Best Plastic Surgery SEO Services”. ... outcome was predictable. Well-known in the plastic surgery ... patients than any other selection based on superior ...
Breaking Medicine News(10 mins):Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 2Health News:Depression May Raise Low Blood Sugar Risk in Diabetics 3Health News:UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery 2Health News:Benefit Express to Host Workplace Wellness Webinar 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2
... from University of Texas observed that Viagra could be ... are accurate, but based on a small experiment in ... translate directly to people with chronic heart and lung ... be useful in treating people with pulmonary hypertension (caused ...
... who were student athletes and have always been slim ... is a rare and invariably fatal neurological condition. It's ... baseball player whose career was cut short by it. ... athletic and developing ALS, as well as motor neurone ...
... a new study in the American Journal of Clinical Nutrition ... role in preventing the build up of plaque in the ... shown antioxidant vitamins can protect against the formation of plaque ... who were already diagnosed with heart disease or who had ...
... new techniques to exercise, one of them being, fitness balls ... more like a children's toy, but they're a powerful new ... of 55 to 65 centimetres diameter. ,The balls ... you have to work your muscles to keep your balance. ...
... a breakthrough discovery, American researchers have found some of the ... the womb. There have always been theories that unborn babies ... is read to or played music while still in the ... has been questionable in the past because there has been ...
... autism. A study in this week's issue of British ... likely than those without it to have had gastrointestinal ... University identified 90 children with autism and compared them ... histories, including when they had the measles, mumps, and ...
Cached Medicine News:
The ImmunoWELL TPO IgG Quantitative Test is a quantitative enzyme immunoassay (EIA) for screening and detection of autoantibodies against human thyroid peroxidase (microsome) in serum and is used as ...
... The ImmunoDOT Autoimmunity Screening Panel 4 ... for screening and detection of autoantibodies ... (SS-A, SS-B, RNP/Sm, and Sm) in ... aid in the diagnosis of systemic ...
The 8500 is an extremely reliable portable pulse oximeter, requiring no periodic maintenance or calibration....
Rad-5 signal extraction pulse oximeter™...
Medicine Products: